Category: Pharmaceutical Industry - Page 2
Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Posted by Ian SInclair On 17 Nov, 2025 Comments (9)
Patent litigation in the generic drug market is delaying affordable medicines. Learn how the Hatch-Waxman Act, Orange Book listings, and serial lawsuits are blocking competition-and what’s being done to fix it.
The History of Thioridazine: A Look Back at its Development
Posted by Ian SInclair On 11 May, 2023 Comments (17)
In my latest blog post, I explored the history of Thioridazine, a medication that has made a significant impact in the field of mental health. I delved into its development, which dates back to the 1950s, when it was first synthesized as a part of a new class of antipsychotic drugs. Thioridazine went on to become a popular treatment option for schizophrenia, offering relief to countless patients. However, over time, concerns about its side effects and potential health risks led to its decline in use. It's fascinating to look back at the journey of Thioridazine and its role in shaping modern psychiatry.
